FDA-approved weight loss medications include injections (Wegovy®, Zepbound®, etc.) and pills, like Qsymia® and Xenical®. Most ...

EMA issues positive opinion on Novo Nordisk's higher-dose Wegovy, supported by strong weight-loss data and ongoing reviews in ...

The European Medicines Agency (EMA) has issued a positive opinion for a new Wegovy® 7.2 mg dose, advancing its availability ...

The FDA has qualified the first AI-based tool that can be used in clinical trials involving patients with metabolic ...

Novo Nordisk submitted a higher-dose version of semaglutide (Wegovy) to the FDA for approval as a weight-management treatment ...

In the midst of regulatory and political upheaval, biopharma’s R&D engine kept running, churning out highs and lows in equal ...

Top FDA officials have internally pushed for a faster review of Eli Lilly’s (LLY) marketing application for its weight loss pill orforglipron. Read more here.

Leaders at the U.S. Food and Drug Administration have pressed internally for reviewers to speed up their evaluation of Eli Lilly's experimental weight‑loss pill, after the company pushed for a faster ...

The first CNPV approval falls into the latter category, and is for a US-manufactured version of the widely used antibiotic ...

Novo Nordisk's 7.2 mg Wegovy injectable aims to enhance chronic weight management in adults with obesity, using an expedited FDA review process. The Phase III STEP UP trial showed semaglutide 7.2 mg's ...

The inaugural approval under the program has gone to USAntibiotics and its domestically manufactured extended-release ...

New obesity treatments, including ‘oral Mounjaro’ and ‘high-dose Wegovy,’ are scheduled to launch next year. The Danish ...